[{"data": {"name": "Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Kelong Han", "@type": "Person"}, {"name": "Thomas Peyret", "@type": "Person"}, {"name": "Angelica Quartino", "@type": "Person"}, {"name": "Nathalie H. Gosselin", "@type": "Person"}, {"name": "Sridharan Gururangan", "@type": "Person"}, {"name": "Michela Casanova", "@type": "Person"}, {"name": "Johannes H. M. Merks", "@type": "Person"}, {"name": "Maura Massimino", "@type": "Person"}, {"name": "Jacques Grill", "@type": "Person"}, {"name": "Najat C. Daw", "@type": "Person"}, {"name": "Fariba Navid", "@type": "Person"}, {"name": "Jin Jin", "@type": "Person"}, {"name": "David E. Allison", "@type": "Person"}], "license": "cc-by-nc-nd", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.12778", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley-Blackwell", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1111/bcp.12778", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCN2X3SZGoNz6-CThGjv82ciTYC-CDA4RCMugvyan-CRgg5xUJtZ8oC", "propertyID": "ISCC"}], "datePublished": "2015-12-10"}, "schema": "schema.org", "mediatype": "application/ld+json"}]